Ampio Pharmaceuticals Inc. (AMEX:AMPE) has a beta value of 1.75 and has seen 1.45 million shares traded in the last trading session. The company, currently valued at $346.80M, closed the last trade at $1.70 per share which meant it lost -$0.03 on the day or -1.73% during that session. The AMPE stock price is -75.29% off its 52-week high price of $2.98 and 61.76% above the 52-week low of $0.65. The 3-month trading volume is 1.85 million shares.
The consensus among analysts is that Ampio Pharmaceuticals Inc. (AMPE) is a Buy stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
Ampio Pharmaceuticals Inc. (AMEX:AMPE) trade information
Sporting -1.73% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on Friday, 09/03/21 when the AMPE stock price touched $1.70 or saw a rise of 2.86%. Year-to-date, Ampio Pharmaceuticals Inc. shares have moved 6.92%, while the 5-day performance has seen it change 8.97%. Over the past 30 days, the shares of Ampio Pharmaceuticals Inc. (AMEX:AMPE) have changed 17.24%.
Wall Street analysts have a consensus price target for the stock at $4.00, which means that the shares’ value could jump 57.5% from current levels. The projected low price target is $4.00 while the price target rests at a high of $4.00. In that case, then, we find that the current price level is -135.29% off the targeted high while a plunge would see the stock gain -135.29% from current levels.
Ampio Pharmaceuticals Inc. (AMPE) estimates and forecasts
Figures show that Ampio Pharmaceuticals Inc. shares have underperformed across the wider relevant industry. The company’s shares have gained 15.65% over the past 6 months, with this year growth rate of 11.11%, compared to 18.50% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 26.60% over the past 5 years.
Ampio Pharmaceuticals Inc. is expected to release its next earnings report between November 01 and November 05 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Ampio Pharmaceuticals Inc. (AMEX:AMPE)’s Major holders
Insiders own 7.05% of the company shares, while shares held by institutions stand at 27.41% with a share float percentage of 29.49%. Investors are also buoyed by the number of investors in a company, with Ampio Pharmaceuticals Inc. having a total of 148 institutions that hold shares in the company. The top two institutional holders are Blackrock Inc. with over 12.14 million shares worth more than $20.27 million. As of Jun 29, 2021, Blackrock Inc. held 6.06% of shares outstanding.
The other major institutional holder is Vanguard Group, Inc. (The), with the holding of over 9.19 million shares as of Jun 29, 2021. The firm’s total holdings are worth over $15.34 million and represent 4.58% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF. As of Jun 29, 2021, the former fund manager holds about 2.61% shares in the company for having 5.24 million shares of worth $8.75 million while later fund manager owns 4.36 million shares of worth $7.28 million as of Jun 29, 2021, which makes it owner of about 2.18% of company’s outstanding stock.